Advanced search
Add to list

Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response

(2019) HEPATOLOGY. 70(suppl. 1). p.783A-785A
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
de Veer, Rozanne, et al. “Second-Line Therapy Is Indicated in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis and High Alkaline Phosphatase despite a Complete Globe-Score Response.” HEPATOLOGY, vol. 70, no. suppl. 1, 2019, pp. 783A-785A.
APA
de Veer, R., Harms, M. H., Corpechot, C., Lammers, W. J., Thorburn, D., Invernizzi, P., … Van der Meer, A. (2019). Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response. In HEPATOLOGY (Vol. 70, pp. 783A-785A). Boston, MA, USA.
Chicago author-date
Veer, Rozanne de, Maren H Harms, Christophe Corpechot, Willem J Lammers, Douglas Thorburn, Pietro Invernizzi, Harry LA Janssen, et al. 2019. “Second-Line Therapy Is Indicated in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis and High Alkaline Phosphatase despite a Complete Globe-Score Response.” In HEPATOLOGY, 70:783A-785A.
Chicago author-date (all authors)
de Veer, Rozanne, Maren H Harms, Christophe Corpechot, Willem J Lammers, Douglas Thorburn, Pietro Invernizzi, Harry LA Janssen, Pier Maria Battezzati, Frederik Nevens, Keith D Lindor, Annarosa Floreani, Cyriel Ponsioen, Marlyn J Mayo, Albert Pares, Andrew L Mason, Kris V Kowdley, Palak J Trivedi, Gideon Hirschfield, Tony Bruns, George N Dalekos, Xavier Verhelst, Bettina E Hansen, Henk R Van Buuren, and Adriaan Van der Meer. 2019. “Second-Line Therapy Is Indicated in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis and High Alkaline Phosphatase despite a Complete Globe-Score Response.” In HEPATOLOGY, 70:783A-785A.
Vancouver
1.
de Veer R, Harms MH, Corpechot C, Lammers WJ, Thorburn D, Invernizzi P, et al. Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response. In: HEPATOLOGY. 2019. p. 783A-785A.
IEEE
[1]
R. de Veer et al., “Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response,” in HEPATOLOGY, Boston, MA, USA, 2019, vol. 70, no. suppl. 1, pp. 783A-785A.
@inproceedings{8653985,
  author       = {de Veer, Rozanne and Harms, Maren H and Corpechot, Christophe and Lammers, Willem J and Thorburn, Douglas and Invernizzi, Pietro and Janssen, Harry LA and Battezzati, Pier Maria and Nevens, Frederik and Lindor, Keith D and Floreani, Annarosa and Ponsioen, Cyriel and Mayo, Marlyn J and Pares, Albert and Mason, Andrew L and Kowdley, Kris V and Trivedi, Palak J and Hirschfield, Gideon and Bruns, Tony and Dalekos, George N and Verhelst, Xavier and Hansen, Bettina E and Van Buuren, Henk R and Van der Meer, Adriaan},
  booktitle    = {HEPATOLOGY},
  issn         = {0270-9139},
  language     = {eng},
  location     = {Boston, MA, USA},
  number       = {suppl. 1},
  pages        = {783A--785A},
  title        = {Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response},
  volume       = {70},
  year         = {2019},
}

Web of Science
Times cited: